THANK YOU FOR SUBSCRIBING
DrugBank's CEO is motivated to link and structure one of the world's biological data and views this alliance as a crucial step.
FREMONT, CA:"We're always looking for ways to improve access to relevant, evidence-based drug information so that our users can quickly and reliably do their best work. Partnering with ASHP not only expands the breadth of information we're able to provide, but it allows for further connections and discoveries within that data. " says Mike Wilson, CEO of DrugBank.
DrugBank and the American Society of Health-System Pharmacists (ASHP) declared their alliance. This move will combine the expertise of both organizations in supplying reliable, dependable data and pave the way for product development collaborations to address industry needs.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
DrugBank will include ASHP's reputable goods and data in its extensive knowledge base before making it accessible via its industry-leading API. Through DrugBank's safe and user-friendly platform, ASHP customers can anticipate excellent delivery reliability and frequency. ASHP's evidence-based information will also be accessible to DrugBank's clientele, which includes 13 of the top 20 pharmaceutical companies and users in over 24 countries.
The American Society of Health-System Pharmacists (ASHP) has long acted as the authority on medication information for pharmacists and medical professionals worldwide. This alliance reflects their dedication to delivering products and services of the highest quality by integrating cutting-edge technologies. The ASHP approached DrugBank for this relationship due to its remarkable reputation for data-knowledge excellence and stewardship.
DrugBank's industry-leading data management system has gained their respect as stewards of the world's most extensive drug knowledge base, which contains information on more than 500,000 medications and medicinal products. This agreement will boost DrugBank's Clinical API, ASHP's mapping capabilities, and the normalization efforts of the healthcare industry. By combining their customer insights and research, businesses would be able to uncover unmet market demands and fulfill them.
More in News